Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
In other words, the price has increased by $0.00 from its previous closing price. On the day, 0.86 million shares were traded. ORGN stock price reached its highest trading level at $1.25 during the session, while it also had its lowest trading level at $1.2.
Ratios:
We take a closer look at ORGN’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 16.16 and its Current Ratio is at 16.27. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, BofA Securities on August 16, 2024, Upgraded its rating to Buy and sets its target price to $3 from $1.35 previously.
On August 11, 2023, Craig Hallum Downgraded its rating to Hold which previously was Buy but kept the price unchanged to $2.
On October 14, 2022, Credit Suisse started tracking the stock assigning a Outperform rating and target price of $7.Credit Suisse initiated its Outperform rating on October 14, 2022, with a $7 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 20 ’24 when Riley Richard J. bought 300,000 shares for $1.00 per share. The transaction valued at 300,000 led to the insider holds 749,083 shares of the business.
Lee Joshua C. sold 8,784 shares of ORGN for $10,906 on Nov 14 ’24. The General Counsel now owns 477,410 shares after completing the transaction at $1.24 per share. On Nov 14 ’24, another insider, Bissell John, who serves as the Co-CEO and Director of the company, sold 6,598 shares for $1.25 each. As a result, the insider received 8,260 and left with 1,617,230 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ORGN now has a Market Capitalization of 181350000 and an Enterprise Value of 39833688. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.25 while its Price-to-Book (P/B) ratio in mrq is 0.50. Its current Enterprise Value per Revenue stands at 1.169 whereas that against EBITDA is -0.702.
Stock Price History:
Over the past 52 weeks, ORGN has reached a high of $1.90, while it has fallen to a 52-week low of $0.44. The 50-Day Moving Average of the stock is -9.02%, while the 200-Day Moving Average is calculated to be 19.43%.
Shares Statistics:
According to the various share statistics, ORGN traded on average about 1.18M shares per day over the past 3-months and 1638920 shares per day over the past 10 days. A total of 145.89M shares are outstanding, with a floating share count of 125.70M. Insiders hold about 14.05% of the company’s shares, while institutions hold 16.60% stake in the company. Shares short for ORGN as of 1730332800 were 3895543 with a Short Ratio of 5.10, compared to 1727654400 on 3417061. Therefore, it implies a Short% of Shares Outstanding of 3895543 and a Short% of Float of 3.09.
